More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-100.0% Growth)
- Ratings (7.3 Score)

Upcoming Events

- Earnings (5/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 101.50 -0.45 (0.44%)
Prev. Close $101.95  
Open$99.00 
52 Wk High$ 
52 Wk Low$ 
Day High$102.10 
Day Low$98.60 
P/E N/A  
EPS$ 
Volume578,366 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, CVAC, NVAX (more...)

Feb 19, 2026 01:15 PM BioNTech sues Moderna for U.S. patent infringement over covid vaccine MNEXspike - Court filing
Feb 12, 2026 08:17 AM Form 144 BioNTech SE Filed by: Medine GmbH
Feb 2, 2026 06:04 AM Leerink Partners Downgrades BioNTech (BNTX) to Market Perform
Jan 28, 2026 08:11 AM Form 6-K BioNTech SE For: Jan 28
Jan 16, 2026 06:49 AM Goldman Sachs Upgrades BioNTech (BNTX) to Buy, 'at the nexus of these significant developments occurring in the oncology field'
Jan 14, 2026 10:40 AM The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era
Jan 14, 2026 06:02 AM Form 6-K BioNTech SE For: Jan 13
Jan 12, 2026 10:53 AM BMO Capital on BioNTech (BNTX): 'Catalyst-Rich 2026 to Spotlight Differentiation of Onc Assets'
Jan 12, 2026 06:58 AM Form 6-K BioNTech SE For: Jan 12
Jan 12, 2026 06:58 AM Form 6-K BioNTech SE For: Jan 12
View All Articles

Entities mentioned with BNTX

View All Entities